Freemelt (FREEM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved record Q2 2025 sales of SEK 19 million, matching full-year 2024 sales and representing a 691% year-over-year increase.
Order intake reached SEK 20 million for the quarter, totaling SEK 42 million for H1 2025, including first industrial order in Germany and new business in energy and defense sectors.
Entered the Chinese market via partnerships with GUD and Jiuli, targeting rapid expansion.
Outsourced manufacturing to Scanfil, strengthening delivery capacity and scalability.
Installed base increased to 39 machines, reflecting strong market traction.
Financial highlights
Q2 2025 net sales were SEK 19,074k, up from SEK 2,410k in Q2 2024; machine sales made up 86% of net sales.
Aftermarket contributed 13% of net sales, with customer projects at 1%.
Order book at quarter end was SEK 14 million, up 47% year-over-year.
Operating result improved to -SEK 20,528k from -SEK 26,739k year-over-year.
Cash at bank at period end was SEK 53,984k, up from SEK 47,179k year-over-year.
Outlook and guidance
Focus on expanding installed base, scaling industrialization, and targeting volume orders for e-MELT® industrial machines.
Continued growth expected in defense, energy, and MedTech sectors, with emphasis on Asian market expansion and supply chain development.
Anticipate improved profitability as new products mature and manufacturing is outsourced.
Management and key personnel's subscription to stock options signals confidence in long-term growth.
Latest events from Freemelt
- Sales up 172% to SEK 54.5m, installed base up 40%, and strong growth in key sectors.FREEM
Q4 202519 Feb 2026 - Q2 saw first eMELT install, new orders, and a rights issue raising cash to 47,179 KSEK.FREEM
Q2 20242 Feb 2026 - First industrial eMELT sale and OEM order drove growth, but losses persisted.FREEM
Q3 202416 Jan 2026 - Industrial 3D printing momentum grows, targeting SEK 1 billion sales by 2030.FREEM
ABGSC Investor Days11 Jan 2026 - Strong Q4 growth, major orders, and capital raise drive expansion in core sectors.FREEM
Q4 202423 Dec 2025 - Strong 2025 growth, fusion breakthroughs, and China entry drive expansion in key verticals.FREEM
Investor Update10 Dec 2025 - Record order book and SEK 90M rights issue drive growth in defense, energy, and MedTech.FREEM
Q1 202521 Nov 2025 - Record Q3 order growth, China expansion, and 96% sales increase drive scale-up despite losses.FREEM
Q3 20254 Nov 2025 - Q1 2024 marked by strategic orders, a 66 MSEK rights issue, and ongoing commercialization focus.FREEM
Q1 202413 Jun 2025